產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-BAALC抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-BAALC抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-BAALC
Cat. Number:
Anti-BAALC抗體KL-9849R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
BAALC is a 180 amino acidAnti-BAALC抗體 protein that localizes to both the membrane and the cytoplasm and exists as multiple alternatively spliced isoforms. Expressed by hematopoetic and neural cells, BAALC interacts with CaMKII and is thought to play a role in synaptic function at postsynaptic lipid rafts. BAALC may be overexpressed in acute myeloid leukemia (AML), suggesting a role in tumorigenesis. The gene encoding BAALC maps to human chromosome 8, which consists of nearly 146 million base pairs, houses more than 800 genes and is associated with a variety of diseases and malignancies. Schizophrenia, bipolar disorder, Trisomy 8, Pfeiffer syndrome, congenital hypothyroidism, Waardenburg syndrome and some leukemias and lymphomas are thought to occur as a result of Anti-BAALC抗體defects in specific genes that maps to chromosome 8.
Also known as:
BAALC; BAALC_HUMAN; Brain and acute leukemia cytoplasmic; Brain and acute leukemia cytoplasmic protein; brain andAnti-BAALC抗體acute leukemia, cytoplasmic; FLJ12015.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BAALC.
●
Predicted Molecular Weight: 19kDa.Anti-BAALC抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working dilutionsAnti-BAALC抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-BAALC抗體 must be determined by the end user.
kl140Mu01 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Po01 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Ra01 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Rb51 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl141Bo01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Hu01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Mu01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Ra01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Si01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl142Hu01 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl142Mu01 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl142Rb51 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl143Ca01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Eq01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Ga01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Po01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
